Professor

Steven Lane

Email: 

Availability

Professor Steven Lane is:
Available for supervision

Search Professor Steven Lane’s works on UQ eSpace

228 works between 1977 and 2026
All (228) Journal Article (173) Conference Publication (55)

1 - 20 of 228 works

2026

Journal Article

Homozygous kinase-dead <i>Csf1r</i> mutation in outbred mice reveals essential and redundant functions of tissue resident macrophages

Jacquelin, Sebastien, Maxwell, Emma, Taylor, Isis, Green, Emma, O’Brien, Conan J O, Jessen, Eline E, Ranpura, Ginell, Guo, Jintao, Nooru-Mohamed, Fathima, Liu, Yajun, Keshvari, Sahar, Huang, Stephen, Cooper, Emily, Lane, Steven W, Flegg, Cameron, Kasherman, Maria A, Sokolowski, Kamil, Pettit, Allison R, Hume, David A and Irvine, Katharine M (2026). Homozygous kinase-dead Csf1r mutation in outbred mice reveals essential and redundant functions of tissue resident macrophages. Journal of Leukocyte Biology qiag074. doi: 10.1093/jleuko/qiag074

Homozygous kinase-dead <i>Csf1r</i> mutation in outbred mice reveals essential and redundant functions of tissue resident macrophages

2026

Journal Article

Single cell long read genotyping of transcripts reveals discrete mechanisms of clonal evolution in post-MPN AML

Grabek, Julian, Straube, Jasmin M, Cooper, Leanne, Halder, Rohit, Zhang, Ranran, Dulige, Inken, Barker, Matthew A, Gatehouse, Will, Christensen, Helen, Amor, Gerlinda, Ling, Victoria Y, McNamara, Caroline, Ross, David M., Perkins, Andrew C, Bywater, Megan J. and Lane, Steven W (2026). Single cell long read genotyping of transcripts reveals discrete mechanisms of clonal evolution in post-MPN AML. Blood Advances bloodadvances.2025018902. doi: 10.1182/bloodadvances.2025018902

Single cell long read genotyping of transcripts reveals discrete mechanisms of clonal evolution in post-MPN AML

2026

Journal Article

Dose-dependent impairment of brain functional and microstructural connectivity during leukaemia chemotherapy

Scott, Ashleigh P., Lo, Ada, Xia, Ying, Thompson, Kate, Bodimeade, Harriet, Fazlollahi, Amir, Weber, Nicholas, Curley, Cameron, Hunt, Stewart, Morris, Kirk, McNamara, Caroline, Perera, Nilu, Subramoniapillai, Elango, Lane, Steven W., Kennedy, Glen A., Salvado, Olivier, Urriola, Javier and McMahon, Katie L. (2026). Dose-dependent impairment of brain functional and microstructural connectivity during leukaemia chemotherapy. British Journal of Haematolog, 208 (5) bjh.70386, 1692-1703. doi: 10.1111/bjh.70386

Dose-dependent impairment of brain functional and microstructural connectivity during leukaemia chemotherapy

2026

Journal Article

CD38+ monocytes fuel fibrosis in myeloproliferative neoplasm

Johansson, Alban and Lane, Steven W. (2026). CD38+ monocytes fuel fibrosis in myeloproliferative neoplasm. Blood, 147 (9), 907-909. doi: 10.1182/blood.2025032444

CD38+ monocytes fuel fibrosis in myeloproliferative neoplasm

2025

Journal Article

How accurate are witnesses of first suspected seizures in recalling semiology at clinically relevant timepoints? A UK experimental study with a pilot intervention

Noble, Adam J., Lane, Steven, New, Paul, Cope, Harriet, Foley, Chloe, Williams, Holly Lynn, Sztriha, Laszlo, Powell, Graham, Reuber, Markus and Marson, Anthony G. (2025). How accurate are witnesses of first suspected seizures in recalling semiology at clinically relevant timepoints? A UK experimental study with a pilot intervention. Epilepsia, 66 (12) epi.18624, 4795-4808. doi: 10.1111/epi.18624

How accurate are witnesses of first suspected seizures in recalling semiology at clinically relevant timepoints? A UK experimental study with a pilot intervention

2025

Journal Article

Australasian Leukaemia and Lymphoma Group. Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study (vol 144, pg 1993, 2024)

Yeung, David T., Shanmuganathan, Naranie, Reynolds, John, Branford, Susan, Walia, Mannu, Yong, Agnes S. M., Shortt, Jake, Chee, Lynette, Viiala, Nicholas, Cunningham, Ilona, Ross, David M., D'Souza, Alwyn, Wright, Matthew, Harrup, Rosemary, Forsyth, Cecily, Filshie, Robin, Lane, Steven, Browett, Peter, Grove, Carolyn, Grigg, Andrew P. and Hughes, Timothy P. (2025). Australasian Leukaemia and Lymphoma Group. Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study (vol 144, pg 1993, 2024). Blood, 146 (22), 2729-2729. doi: 10.1182/blood.2025031951

Australasian Leukaemia and Lymphoma Group. Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study (vol 144, pg 1993, 2024)

2025

Conference Publication

Research Alliance for Urban Goori Health: healthcare records across primary and tertiary healthcare services for Aboriginal and Torres Strait Islander people in South East Queensland

Sanjida, Saira, Lane, Steven, Butler, Danielle, Shakeshaft, Anthony, Sullivan, Clair and Ward, James (2025). Research Alliance for Urban Goori Health: healthcare records across primary and tertiary healthcare services for Aboriginal and Torres Strait Islander people in South East Queensland. The 21st Annual International Conference on Urban Health, Wellington, New Zealand, 17-21 November 2025.

Research Alliance for Urban Goori Health: healthcare records across primary and tertiary healthcare services for Aboriginal and Torres Strait Islander people in South East Queensland

2025

Journal Article

Decoding RNA modifications to unlock new treatments for AML

Lane, Steven W. and Bywater, Megan (2025). Decoding RNA modifications to unlock new treatments for AML. Blood, 146 (20), 2378-2379. doi: 10.1182/blood.2025030290

Decoding RNA modifications to unlock new treatments for AML

2025

Conference Publication

Unravelling the epigenetic drivers of chip – MDS/CMML – AML progression through novel methylation-sensitive regulatory elements

Liu, Yanjing, Chai, Li, Hiwase, Devendra, Ross, David, Yeung, David, Yong, Agnes, Lane, Steven, Brown, Anna, Fong, Chun Yew, Hughes, Timothy, Reynolds, John, Thomas, Daniel, Tenen, Daniel and Bassal, Mahmoud (2025). Unravelling the epigenetic drivers of chip – MDS/CMML – AML progression through novel methylation-sensitive regulatory elements. 67th ASH Annual Meeting, Orlando, FL, United States, 6-9 December 2025. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood-2025-3231

Unravelling the epigenetic drivers of chip – MDS/CMML – AML progression through novel methylation-sensitive regulatory elements

2025

Conference Publication

Durable efficacy of lenzilumab plus azacitidine in newly diagnosed proliferative CMML patients: Interim analysis after four years of study commencement

Hiwase, Devendra, Ross, David, Yeung, David, Yong, Agnes, Lane, Steven, Brown, Anna, Fong, Chun Yew, Hughes, Timothy, Reynolds, John and Thomas, Daniel (2025). Durable efficacy of lenzilumab plus azacitidine in newly diagnosed proliferative CMML patients: Interim analysis after four years of study commencement. 67th American Society of Hematology Annual Meeting and Exposition, Orlando, FL United States, 6–9 December 2025. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2025-3855

Durable efficacy of lenzilumab plus azacitidine in newly diagnosed proliferative CMML patients: Interim analysis after four years of study commencement

2025

Conference Publication

JAK2V617F myeloproliferative neoplasm-propagating stem cells and pegifna treatment alter the bone marrow niche

Johansson, Alban, Bywater, Megan, Shakhovskoy, Michael, Haldar, Rohit, Cooper, Leanne, Lane, Steven and Straube, Jasmin (2025). JAK2V617F myeloproliferative neoplasm-propagating stem cells and pegifna treatment alter the bone marrow niche. 54th Annual Scientific Meeting of the ISEH - International Society for Experimental Hematology, Kumamoto, Japan, 24-27 September 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.exphem.2025.105093

JAK2V617F myeloproliferative neoplasm-propagating stem cells and pegifna treatment alter the bone marrow niche

2025

Journal Article

Bcl-xL inhibition potentiates interferon-induced apoptosis in MPN stem cells

Bywater, Megan J., Haldar, Rohit, Janardhanan, Yashaswini, Cooper, Emily, Cooper, Leanne, Chan, Siu Hang Natalie, Hayes, Noah Jack, Ling, Victoria, Straube, Jasmin M. and Lane, Steven W. (2025). Bcl-xL inhibition potentiates interferon-induced apoptosis in MPN stem cells. Blood Advances, 9 (22), 5915-5919. doi: 10.1182/bloodadvances.2025017242

Bcl-xL inhibition potentiates interferon-induced apoptosis in MPN stem cells

2025

Journal Article

Durable responses to lenzilumab: azacitidine combination therapy in high risk proliferative chronic myelomonocytic leukaemia with suppression of CBL and RAS mutant subclones

Thomas, Daniel, Ross, David, Hughes, Timothy, Yeung, David, Kutyna, Monika, Lim, Kelly, Lane, Steven, Yong, Agnes, Reynolds, John and Hiwase, Devendra (2025). Durable responses to lenzilumab: azacitidine combination therapy in high risk proliferative chronic myelomonocytic leukaemia with suppression of CBL and RAS mutant subclones. EMJ Hematology, 13 (1), 66-67. doi: 10.33590/emjhematol/wvmu7856

Durable responses to lenzilumab: azacitidine combination therapy in high risk proliferative chronic myelomonocytic leukaemia with suppression of CBL and RAS mutant subclones

2025

Journal Article

Assessing the performance of paediatric early warning scores to predict critical deterioration events in hospitalised children (the DETECT study): a retrospective matched case-control study

Bracken, Abbey, Lane, Steven, Siner, Sarah, Jones, Dawn, Lambert, Caroline, Mehta, Fulya, Eyton-Chong, Chin-Kien, Davis, Peter, Fitzsimons, John, Lim, Emma, Clerihew, Linda, Carter, Bernie, Sefton, Gerri and Carrol, Enitan D. (2025). Assessing the performance of paediatric early warning scores to predict critical deterioration events in hospitalised children (the DETECT study): a retrospective matched case-control study. BMC Pediatrics, 25 (1) 520, 1-10. doi: 10.1186/s12887-025-05754-x

Assessing the performance of paediatric early warning scores to predict critical deterioration events in hospitalised children (the DETECT study): a retrospective matched case-control study

2025

Journal Article

Clinical prediction models for febrile neutropenia and its outcomes: a systematic review

Sheehy, Joshua, Gallanagh, Marianne, Sullivan, Clair and Lane, Steven (2025). Clinical prediction models for febrile neutropenia and its outcomes: a systematic review. Supportive Care in Cancer, 33 (7) 537, 537. doi: 10.1007/s00520-025-09562-y

Clinical prediction models for febrile neutropenia and its outcomes: a systematic review

2025

Journal Article

Prevention, diagnosis and management of myeloproliferative neoplasms: an introduction to a review series

Yuan, Yin and Lane, Steven W. (2025). Prevention, diagnosis and management of myeloproliferative neoplasms: an introduction to a review series. Haematologica, 110 (4), 825-827. doi: 10.3324/haematol.2024.285414

Prevention, diagnosis and management of myeloproliferative neoplasms: an introduction to a review series

2025

Journal Article

ALLG APML5: Bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL

Iland, Harry J., Reynolds, John, Boddy, Alan, Schultz, Hayley B., Khoo, Liane, Fleming, Shaun A., Lane, Steven W., Weber, Nicholas, Gasiorowski, Robin, Armytage, Tasman, Harrup, Rosemary Anne, Watson, Anne-Marie, Tan, Peter, Filshie, Robin, Kwok, Fiona, Stevenson, William S., Yuen, Sam L.S., Ng, Ashley Peng Chee, Rowley, Leesa, Marlton, Paula and Wei, Andrew H. (2025). ALLG APML5: Bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL. Blood Advances, 9 (6), 1476-1484. doi: 10.1182/bloodadvances.2024015397

ALLG APML5: Bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL

2025

Journal Article

The PRECISION study protocol: Can cervical stiffness in the second trimester predict preterm birth in high-risk singleton pregnancies? A feasibility, cohort study

Medford, Elizabeth, Lane, Steven, Sharp, Andrew and Care, Angharad (2025). The PRECISION study protocol: Can cervical stiffness in the second trimester predict preterm birth in high-risk singleton pregnancies? A feasibility, cohort study. PLoS One, 20 (2) e0316297, 1-13. doi: 10.1371/journal.pone.0316297

The PRECISION study protocol: Can cervical stiffness in the second trimester predict preterm birth in high-risk singleton pregnancies? A feasibility, cohort study

2024

Conference Publication

High Dose Ascorbate Reduces Interleukin-1 Beta Secretion in TET2 Mutant Monocytes and Demonstrates Excellent Safety and Tolerability in CMML Patients in Combination with Azacitidine

Kamel, Maha M., Robinson, Nirmal, Kutyna, Monika, Lim, Kelly, Thompson-Peach, Chloe, Lane, Steven W., Yeung, David T., Yong, Agnes S. M., Ross, David M., Hiwase, Devendra and Thomas, Daniel (2024). High Dose Ascorbate Reduces Interleukin-1 Beta Secretion in TET2 Mutant Monocytes and Demonstrates Excellent Safety and Tolerability in CMML Patients in Combination with Azacitidine. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-204177

High Dose Ascorbate Reduces Interleukin-1 Beta Secretion in TET2 Mutant Monocytes and Demonstrates Excellent Safety and Tolerability in CMML Patients in Combination with Azacitidine

2024

Conference Publication

Update of the Ascend-CML Study of Frontline Asciminib: High Rate of Optimal Response and Resistance Due to Mutations Is Rare

Yeung, David T., Shanmuganathan, Naranie, Yong, Agnes S. M., Shortt, Jake, Chee, Lynette C.Y., Vialla, Nicholas, Cunningham, Ilona, Ross, David M., D'Souza, Alwyn, Wright, Matthew P.F., Harrup, Rosemary, Forsyth, Cecily, Filshie, Robin, Lane, Steven W., Browett, Peter J., Grove, Carolyn S., Walia, Mannu, Branford, Susan, Reynolds, John, Grigg, Andrew P. and Hughes, Timothy P. (2024). Update of the Ascend-CML Study of Frontline Asciminib: High Rate of Optimal Response and Resistance Due to Mutations Is Rare. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-201218

Update of the Ascend-CML Study of Frontline Asciminib: High Rate of Optimal Response and Resistance Due to Mutations Is Rare

Availability

Professor Steven Lane is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Integrating Genomic Risk, MRD Monitoring and Diagnostic AI to Transform Precision Care in Acute Myeloid Leukaemia

    Associate Advisor

Completed supervision

Enquiries

For media enquiries about Professor Steven Lane's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au